Drug intelligence / Profile preview

OX640

Development stage
Phase 1
Lead developer
Orexo
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Intranasal
01

Overview

OX640 is a powder-based, intranasal epinephrine (adrenaline) rescue medication developed for the acute treatment of severe allergic reactions, including anaphylaxis. It utilizes Orexo’s proprietary AmorphOX drug delivery platform, which enables rapid systemic absorption of epinephrine after nasal administration and offers improved physical and chemical stability compared to traditional injectable formulations. The product is designed as a needle-free alternative to auto-injectors, providing greater convenience, longer shelf life, and more flexible storage conditions. Clinical studies have shown that OX640 achieves clinically relevant plasma levels of epinephrine more rapidly than intramuscular injection products—even in patients with allergic rhinitis—supporting its use as a fast-acting emergency therapy for anaphylaxis[1][3][4][5].

02

Targets

ADRA1A (α1A)ADRA2A (α2A)ADRB1 (β1)ADRB2 (β2)

Beyond the preview

Go deeper on OX640.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OX640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call